文献速递重症综合管理与镇静镇痛

动态病情严重度评分用于定期评估危重患者死亡风险的前瞻性评价

Prospective Evaluation of a Dynamic Acuity Score for Regularly Assessing a Critically Ill Patient's Risk of Mortality.
PubMed 文献 · Crit Care Med · 2023-05-30
一句话结论ViSIG评分用近实时前瞻性数据将ICU患者分为三组,死亡率分别为1.7%、12.0%和39.8%(p<0.001),高危组敏感性51%、特异性91%。

本研究在5个成人ICU和1个成人ICU共纳入2020年8月至12月的1810例入院患者,将前瞻性近实时收集的心率、呼吸频率、氧饱和度、平均动脉压、机械通气及OBS Medical Visensia指数数据,用于验证既往构建的ICU死亡滚动预测模型ViSIG评分;出院转归数据为回顾性收集以评估准确性。患者最大ViSIG评分分为0-37(低危)、38-58(中危)、59-100(高危)三组,对应死亡率分别为1.7%、12.0%、39.8%(p<0.001)。高危组预测死亡的敏感性和特异性分别为51%和91%,验证数据集表现仍高;各风险组间住院时间、估计费用和再入院率呈相似升高。作者认为ViSIG评分风险分层敏感性好、特异性优,未来将研究向临床医生展示该评分能否影响行为以减少不良结局。

要点

  • ViSIG评分由心率、呼吸频率、氧饱和度、平均动脉压、机械通气和OBS Medical Visensia指数值的严重度权重构成。
  • 最大ViSIG评分0-37为低危、38-58为中危、59-100为高危,三组ICU死亡率分别为1.7%、12.0%、39.8%(p<0.001)。
  • 高危组预测死亡的敏感性为51%、特异性为91%,验证数据集表现仍高。
  • 各风险组间住院时间、估计费用和再入院率呈相似升高。
  • 作者计划未来研究向临床医生展示ViSIG评分,以确定该指标能否影响临床医生行为以减少不良结局。

适用人群与场景

  • 2020年8月至12月Robert Wood Johnson-Barnabas大学医院5个成人ICU和Stamford医院1个成人ICU的1810例入院患者。

诊断标准与关键阈值

  • ViSIG评分由心率、呼吸频率、氧饱和度、平均动脉压、机械通气及OBS Medical Visensia指数值的严重度权重构成。
  • 最大ViSIG评分分层:0-37为低危,38-58为中危,59-100为高危。

研究设计与关键结果

  • 研究类型:前瞻性收集数据、回顾性收集出院转归数据,用于验证既往构建的ICU死亡滚动预测模型ViSIG评分;样本量1810例入院,来自Robert Wood Johnson-Barnabas大学医院5个成人ICU和Stamford医院1个成人ICU;人群为2020年8月至12月ICU入院患者;干预/暴露为ViSIG评分,对照无;主要终点为ICU死亡率分层。
  • 最大ViSIG评分0-37(低危)、38-58(中危)、59-100(高危)三组ICU死亡率分别为1.7%、12.0%、39.8%(p<0.001)。
  • 高危组预测死亡的敏感性为51%,特异性为91%。
  • 验证数据集上模型表现仍高。
  • 各风险组间住院时间、估计费用和再入院率呈相似升高。

证据类型、等级与局限

  • 证据类型:前瞻性数据收集的预测模型验证研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ViSIG评分可基于近实时前瞻性数据对ICU患者进行死亡风险分层,高危组特异性为91%;作者计划未来研究向临床医生展示ViSIG评分,以确定该指标能否影响临床医生行为以减少不良结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Predictive models developed for use in ICUs have been based on retrospectively collected data, which does not take into account the challenges associated with live, clinical data. This study sought to determine if a previously constructed predictive model of ICU mortality (ViSIG) is robust when using data collected prospectively in near real-time.

DESIGN: Prospectively collected data were aggregated and transformed to evaluate a previously developed rolling predictor of ICU mortality.

SETTING: Five adult ICUs at Robert Wood Johnson-Barnabas University Hospital and one adult ICU at Stamford Hospital.

PATIENTS: One thousand eight hundred and ten admissions from August to December 2020.

MEASUREMENTS AND MAIN RESULTS: The ViSIG Score, comprised of severity weights for heart rate, respiratory rate, oxygen saturation, mean arterial pressure, mechanical ventilation, and values for OBS Medical's Visensia Index. This information was collected prospectively, whereas data on discharge disposition was collected retrospectively to measure the ViSIG Score's accuracy. The distribution of patients' maximum ViSIG Score was compared with ICU mortality rate, and cut points determined where changes in mortality probability were greatest. The ViSIG Score was validated on new admissions. The ViSIG Score was able to stratify patients into three groups: 0-37 (low risk), 38-58 (moderate risk), and 59-100 (high risk), with mortality of 1.7%, 12.0%, and 39.8%, respectively ( p < 0.001). The sensitivity and specificity of the model to predict mortality for the high-risk group were 51% and 91%. Performance on the validation dataset remained high. There were similar increases across risk groups for length of stay, estimated costs, and readmission.

CONCLUSIONS: Using prospectively collected data, the ViSIG Score produced risk groups for mortality with good sensitivity and excellent specificity. A future study will evaluate making the ViSIG Score visible to clinicians to determine whether this metric can influence clinician behavior to reduce adverse outcomes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kramer AA, Krinsley JF, Lissauer M, et al. Prospective Evaluation of a Dynamic Acuity Score for Regularly Assessing a Critically Ill Patient's Risk of Mortality. Crit Care Med. 2023. PMID: 37246915. doi:10.1097/CCM.0000000000005931

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。